Niagen Bioscience Inc (NAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | 1,566 | 3,937 | 8,830 | 7,332 | 235 |
| Cost of Goods | 617 | 2,074 | 4,702 | 3,881 | -419 |
| Gross Profit | 949 | 1,863 | 4,127 | 3,451 | 655 |
| Operating Expenses | 4,372 | 2,861 | 4,458 | 3,878 | 1,388 |
| Operating Income | -2,806 | -924 | 371 | 454 | -1,153 |
| Interest Expense | -2 | 2 | 145 | 189 | 133 |
| Other Income | -4 | 3 | -313 | 1 | -2 |
| Pre-tax Income | -2,808 | -923 | -87 | 266 | -1,289 |
| Income Tax | N/A | 3 | 4 | 11 | N/A |
| Net Income Continuous | -2,790 | -926 | -91 | 256 | -1,293 |
| Net Income Discontinuous | 651 | -28 | N/A | N/A | N/A |
| Net Income | $-2,139 | $-954 | $-91 | $256 | $-1,427 |
| EPS Basic Total Ops | -0.06 | -0.03 | 0.00 | 0.01 | -0.04 |
| EPS Basic Continuous Ops | -0.08 | -0.02 | 0.00 | 0.01 | -0.03 |
| EPS Basic Discontinuous Ops | 0.02 | 0.00 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -0.06 | -0.03 | 0.00 | 0.01 | -0.04 |
| EPS Diluted Continuous Ops | -0.08 | -0.02 | 0.00 | 0.01 | -0.03 |
| EPS Diluted Discontinuous Ops | 0.02 | 0.00 | N/A | N/A | N/A |
| EBITDA(a) | $-2,684 | $-824 | $475 | $548 | $-1,065 |